Recruiting at 1 site No phase Major Depressive Episode

Clinical trial for Major Depressive Episode

Official title The Impact of Coach-guided Risk Communication on the Risk of Major Depression

ClinicalTrials.gov ID: NCT06619366

What this study is testing

What it's testing
This study aims to find out if a personalized risk communication tool, guided by a coach, can lower the chance of developing major depression. It also looks at whether this tool encourages people to use self-help strategies and seek help.
Who it's for
The study is looking for men and women across Canada who are at high risk of developing depression.
What's involved
Participants will be randomly assigned to either use the personalized risk communication tool with coaching or a control group. They will receive information about their specific depression risk factors and evidence-based self-help strategies.
Time commitment
The study lasts for 12 months, during which participants will be followed to track their mental health and engagement with the tools.
  • Time commitment: about 12 months
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 65

You may be able to join if

  • no MDE at baseline, or full remission for 2 months for those who had a past MDE (see below the question).
  • Aged 18 and 65 years.
  • At high risk of MDE based on the depression risk calculators (predicted risk of 6.5%+ for males and 11.2%+ for females), which represent the top two...
  • Agreement to be contacted for follow-up assessments, and
  • no language barriers to English or French

You likely can't join if

  • individuals who
  • cannot provide informed consent,
  • do not agree to be followed,
  • cannot communicate in English and French, or
  • report suicide behaviors (score \>0 on item 9 of the Patient Health Questionnaire (PHQ-9)).

The study team makes the final eligibility decision.

Where it is enrolling

  • Halifax, Nova Scotia, Canada

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Halifax, Nova Scotia, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.